IMUX
Immunic, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:57 PM EST
7.50USD+2.319%(+0.17)175,591
Pre-marketNov 18, 2026 8:48:30 AM EST
7.55USD+3.001%(+0.22)
After-hoursNov 18, 2026 4:00:30 PM EST
7.52USD+0.267%(+0.02)
IMUX Financials
In Q3 FY 2026 (ended ), Immunic, Inc. Common Stock (IMUX) reported net income of −$42.31M, operating cash flow of −$28.39M, and assets of $136.42M (filed ).
Loading financial statements…